Source: streetinsider

Press Release: The Trout Group : Vericel to Present at the BIO CEO & Investor Conference

Vericel Corporation (NASDAQ: VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, president and CEO, will present the latest company overview at the BIO CEO & Investor Conference in New York, NY on Monday, February 12, 2018 at 3:00pm Eastern time.

Read full article »
The Trout Group's Competitors | The Trout Group's News | The Trout Group's Financials
Stay up-to-date with the latest news on The Trout Group
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jonathan B. Fassberg's photo - Founder & CEO of The Trout Group

Founder & CEO

Jonathan B. Fassberg

CEO Approval Rating

69/100

Read more
Stay up-to-date with the latest news on The Trout Group